May 10 (SeeNews) - Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said it booked a net loss of 7.2 million marka ($4 million/3.7 million euro) in the first quarter of the year, compared with a net loss of 13.1 million marka recorded in the like period a year earlier.
Total revenue went up 21.7% year-on-year to 20 million marka, whereas total expenses fell 7.7% to 27.3 million marka in the January-March period, Bosnalijek said in a filing to the Sarajevo Stock Exchange (SASE) on Tuesday.
The company's shares last traded on SASE on May 5, closing flat at 30 marka.
Bosnalijek is the largest pharmaceuticals company in Bosnia and Herzegovina.
(1 euro = 1.95583 marka)